Market Tracker

04/28 5:16pm ET

Geron Corp (NASDAQ:GERN)

2.56
Delayed Data
As of Apr 28
 -0.07 / -2.66%
Today’s Change
1.81
Today|||52-Week Range
3.16
+23.67%
Year-to-Date
Will Geron (GERN) Continue to Surge Higher?
Apr 28 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for April 18th
Apr 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close2.63
Today’s open2.63
Day’s range2.53 - 2.64
Volume1,591,327
Average volume (3 months)1,669,118
Market cap$407.4M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...-0.17-1.70%
XBITXBiotech Inc0.000.00%
IMGNImmunoGen Inc-0.01-0.23%
BTXBioTime Inc-0.04-1.16%
Data as of 4:07pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts